CXCL13 antagonists and their use for the treatment of inflammatory diseases

Details for Australian Patent Application No. 2007240355 (hide)

Owner Centocor, Inc.

Inventors Das, Anuk; Sarisky, Robert A.; Shang, Xiaozhou; Bugelski, Peter; Liang, Bailin; Li, Li; Griswold, Donald E.

Agent Shelston IP

Pub. Number AU-A-2007240355

PCT Pub. Number WO2007/124414

Priority 60/909,128 30.03.07 US; 60/794,018 21.04.06 US

Filing date 20 April 2007

Wipo publication date 1 November 2007

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

13 November 2008 PCT application entered the National Phase

  PCT publication WO2007/124414 Priority application(s): WO2007/124414

26 February 2009 Amendment Made

  The nature of the amendment is: Amend the name of the co-inventors to read from Sarisky, Robert A. to Sarisky, Robert T. and from Griswold, Donald E. to Griswold, Don E.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007240364-IL-8 receptor antagonists

2007240353-Heating of multiple layers in a hydrocarbon-containing formation